A genetic map of the developing brain, waiting to be read.
Somewhere in the architecture of the developing brain, 331 genes hold the instructions for building a mind — and when even one fails, the consequences can be profound and invisible for years. An international team led by researchers at The Hebrew University of Jerusalem has completed a sweeping genetic survey of early neural development, using CRISPR technology to test nearly every human gene for its role in forming brain cells. Beyond the catalog itself, the work named a previously unknown disorder in two children and opened a shared database that may help future families find answers where none existed before.
- Roughly 20,000 human genes were systematically disabled one by one in embryonic stem cells, creating an unprecedented stress test of the developing brain's genetic requirements.
- Two unrelated children — each with smaller-than-normal brains and severe developmental delays — had gone undiagnosed until the screening pointed directly to mutations in a single gene, PEDS1.
- The discovery that metabolic genes like PEDS1 follow recessive inheritance patterns, while regulatory genes tend toward dominant ones, gives clinicians a new framework for prioritizing genetic investigations.
- A distinction is emerging between genes tied to developmental delay and those linked to autism, suggesting that overlapping symptoms may have distinct genetic origins depending on when in development a gene is most critical.
- The full dataset has been made publicly available through an open online database, turning a single study into a living resource for researchers worldwide still searching for the genes behind unnamed disorders.
A team of international researchers has produced what may be the most comprehensive genetic map of early brain development to date — a systematic catalog, published in Nature Neuroscience, of the 331 genes the body requires to transform embryonic stem cells into neurons. Led by Prof. Sagiv Shifman at The Hebrew University of Jerusalem and collaborators at INSERM in France, the project began with a foundational question: which of the roughly 20,000 genes in the human genome are truly essential for building a brain?
To find out, the team used CRISPR gene-editing technology to disable genes one by one in embryonic stem cells, watching which disruptions derailed the transformation into brain cells. Many of the 331 genes identified had never before been connected to neural development. But the most consequential discovery was a gene called PEDS1, which produces plasmalogens — molecules that form part of myelin, the insulation around nerve fibers. When PEDS1 is absent, the brain grows smaller than normal.
The hypothesis that PEDS1 mutations could cause human disease was confirmed through genetic testing of two unrelated families, each with a child suffering from developmental delay and reduced brain size. Both children carried rare mutations in the same gene. Experimental models corroborated the clinical findings, establishing PEDS1 as the cause of a previously unnamed neurodevelopmental disorder.
The research also surfaced a pattern with practical implications: regulatory genes tend to cause dominant disorders, while metabolic genes like PEDS1 typically cause recessive ones — a relationship that could help clinicians decide which genes to investigate first. The team further found that genes broadly active throughout development are more associated with developmental delay, while those critical specifically during neuron formation are more strongly linked to autism.
PhD student Alana Amelan, who conducted much of the experimental work, also built an open-access website to share the complete dataset with researchers worldwide. The database transforms the study from a single publication into a shared foundation — one that may help name disorders still waiting to be discovered, and offer clearer answers to families navigating a diagnosis that does not yet exist.
A team of international researchers has completed what amounts to a genetic inventory of the developing brain—a systematic catalog of which genes the body needs to build a functioning nervous system, and what breaks when those genes fail. The work, published in Nature Neuroscience, identified 331 genes essential for turning embryonic stem cells into neurons, and in the process uncovered a previously unknown genetic disorder that affects two children across unrelated families.
The research began with a deceptively simple question: which of the roughly 20,000 genes in the human genome are actually required for early brain development? To answer it, scientists led by Prof. Sagiv Shifman at The Hebrew University of Jerusalem, working with collaborators at INSERM in France, deployed CRISPR gene-editing technology to systematically disable genes one by one. They performed this massive screening in embryonic stem cells, watching as the cells transformed into brain cells, and tracked which genetic disruptions derailed the process. The approach was methodical and comprehensive—a kind of genetic stress test that revealed which genes the developing brain cannot do without.
Many of the 331 genes they identified had never before been linked to neural development. The findings offer a new lens for understanding neurodevelopmental conditions: altered brain size, autism, developmental delay. But the most striking discovery emerged from the screening itself. The researchers found that a gene called PEDS1—which produces plasmalogens, specialized molecules that form part of myelin, the insulation around nerve fibers—plays a critical role in brain cell formation. When PEDS1 is absent, the brain develops smaller than normal. This observation led them to a hypothesis: could PEDS1 mutations cause disease in humans?
Genetic testing of two unrelated families provided the answer. Both families had children with severe developmental disorders marked by developmental delay and reduced brain size. Both children carried rare mutations in PEDS1. When the researchers inactivated the gene in experimental models, the results confirmed what the clinical cases suggested: PEDS1 is essential for normal brain development, including the generation and migration of nerve cells. A previously unknown disorder had been identified and its genetic cause established.
The research also revealed a pattern that may help clinicians prioritize which genes to investigate in future cases. Genes that regulate other genes—those involved in transcription and chromatin control—tend to cause dominant disorders, where a mutation in just one copy of the gene is enough to cause disease. Metabolic genes like PEDS1, by contrast, typically cause recessive disorders, requiring mutations in both copies. This relationship between biological function and inheritance pattern could accelerate the identification of disease genes. The team also found that genes broadly essential throughout development are more strongly associated with developmental delay, while genes critical specifically during nerve cell formation are more strongly linked to autism—a distinction that helps explain how different genetic disruptions can produce overlapping symptoms.
Shifman and his colleagues have made their complete dataset publicly available through an open online database, a decision driven by PhD student Alana Amelan, who carried out much of the experimental work and built the website. The resource is now accessible to researchers worldwide, transforming what could have been a single paper into a shared foundation for ongoing discovery. As neurodevelopmental disorders continue to challenge diagnosis and treatment, this genetic map offers both immediate clinical utility—better genetic counseling for affected families—and a template for identifying the genes behind conditions yet to be named.
Citas Notables
By tracking the differentiation of embryonic stem cells into neural cells and systematically disrupting nearly all genes in the genome, we created a map of the genes essential for brain development. This map can help us better understand how the brain develops and identify genes linked to neurodevelopmental disorders that have yet to be discovered.— Prof. Sagiv Shifman, Hebrew University of Jerusalem
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that you can now name 331 genes instead of knowing nothing about them?
Because every gene you can name is a potential explanation for why a child's brain developed differently. Right now, families with developmental disorders often get no genetic diagnosis at all. This map gives clinicians places to look.
But you found one new disorder—PEDS1. Does that mean there are hundreds more waiting to be discovered?
Almost certainly. The researchers identified genes involved in brain development, but they haven't yet found all the human families carrying mutations in those genes. The database they released is meant to accelerate that work.
The two children with PEDS1 mutations—are they related?
No, they're from unrelated families. That's actually significant. It suggests PEDS1 mutations aren't vanishingly rare, just rare enough that you need a systematic genetic screen to find them.
You mentioned that metabolic gene disorders are recessive. What does that mean for those families?
Both parents carry one mutated copy and one normal copy. They're unaffected because one working copy is enough. But when both parents pass on their mutated copy, the child gets none that work. Genetic counseling can now explain this clearly to families.
Why does it matter whether a gene is essential throughout development versus just during nerve cell formation?
Because it tells you what the disorder will look like. Broadly essential genes disrupt many systems and cause developmental delay. Genes critical only during specific neural stages tend to produce autism-like features. The same disruption, different timing, different outcome.
What happens next with this research?
The database is live. Other researchers will use it to hunt for mutations in their patient populations. Some of those 331 genes will likely become names of disorders, like PEDS1 just did. The real work is just beginning.